SAB Biotherapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
SAB Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • SAB Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 9.26M shares, a 83.6% increase year-over-year.
  • SAB Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5.52M shares, a 26.9% increase from 2022.
  • SAB Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.35M shares, a 84.1% decline from 2021.
  • SAB Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 27.3M shares, a 7.67% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 5.52M +1.17M +26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 4.35M -23M -84.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 27.3M +1.95M +7.67% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 25.4M Jan 1, 2020 Dec 31, 2020 10-K/A 2023-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.